Cell therapy medical tourism: Time for action
Kurt C. Gunter(Medica (United States)), Edwin M. Horwitz(St. Jude Children's Research Hospital), John E.J. Rasko(Macau University of Science and Technology), William E. Janssen(St. Jude Children's Research Hospital), Arthur L. Caplan(Institute of Medical Ethics), Rachel Salzman(The Stop ALD Foundation), Akihiro Shimosaka(Japan Association for Development of Community Medicine), Karen Nichols(ImmunityBio (United States)), Chris Mason(Oak Ridge National Laboratory), Francesco Lanza(Ospedale "Santa Maria delle Croci" di Ravenna), Luís Fernando S. Bouzas(Instituto Nacional de Câncer - INCA), Bruce L. Levine(University of Pennsylvania)
Cited by 51
Related Papers
A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
BTRFS
|ACM Transactions on Storage|2013|381
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey
|Bone Marrow Transplantation|2016|309
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276